nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An unusual cause for neoplastic eosinophilia: nothing on morphology
|
Goel, Manisha |
|
|
136 |
19 |
p. 2242 |
artikel |
2 |
Bone marrow–derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis
|
Xiao, Yanling |
|
|
136 |
19 |
p. 2188-2199 |
artikel |
3 |
“Breaking down” the mechanisms of expansion
|
O'Leary, Heather A. |
|
|
136 |
19 |
p. 2095-2096 |
artikel |
4 |
COVID-19–induced atypical pulmonary lymphocytes
|
Vergé, Véronique |
|
|
136 |
19 |
p. 2241 |
artikel |
5 |
Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma
|
Chen, Jungang |
|
|
136 |
19 |
p. 2175-2187 |
artikel |
6 |
Editorial Board
|
|
|
|
136 |
19 |
p. i |
artikel |
7 |
How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease
|
Leebeek, Frank W.G. |
|
|
136 |
19 |
p. 2143-2150 |
artikel |
8 |
How I treat lymphoma in pregnancy
|
Dunleavy, Kieron |
|
|
136 |
19 |
p. 2118-2124 |
artikel |
9 |
How I treat thrombotic thrombocytopenic purpura in pregnancy
|
Ferrari, Barbara |
|
|
136 |
19 |
p. 2125-2132 |
artikel |
10 |
How I treat venous thromboembolism in pregnancy
|
Middeldorp, Saskia |
|
|
136 |
19 |
p. 2133-2142 |
artikel |
11 |
Implicating ILK in inflammation
|
Plow, Edward F. |
|
|
136 |
19 |
p. 2097-2099 |
artikel |
12 |
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation
|
Diral, Elisa |
|
|
136 |
19 |
p. 2237-2240 |
artikel |
13 |
Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation
|
Tsoukas, Paul |
|
|
136 |
19 |
p. 2162-2174 |
artikel |
14 |
Introduction to a How I Treat series on hematologic complications in pregnancy
|
Bollard, Catherine |
|
|
136 |
19 |
p. 2093 |
artikel |
15 |
Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171
|
Subramaniam, Agatheeswaran |
|
|
136 |
19 |
p. 2151-2161 |
artikel |
16 |
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group
|
Fakhouri, Fadi |
|
|
136 |
19 |
p. 2103-2117 |
artikel |
17 |
Maternal hepcidin determines embryo iron homeostasis in mice
|
Sangkhae, Veena |
|
|
136 |
19 |
p. 2206-2216 |
artikel |
18 |
Maternal hepcidin: the only player on the field?
|
Fleming, Robert E. |
|
|
136 |
19 |
p. 2099-2100 |
artikel |
19 |
PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153
|
Han, Xu |
|
|
136 |
19 |
p. 2217-2228 |
artikel |
20 |
Popping the lid on PAR4 activation
|
Holinstat, Michael |
|
|
136 |
19 |
p. 2101-2102 |
artikel |
21 |
Preexisting or therapy-induced mutations in relapsed acute lymphoblastic leukemia?
|
Gaynon, Paul S. |
|
|
136 |
19 |
p. 2233-2235 |
artikel |
22 |
The integrin-linked kinase is required for chemokine-triggered high-affinity conformation of the neutrophil β2-integrin LFA-1
|
Margraf, Andreas |
|
|
136 |
19 |
p. 2200-2205 |
artikel |
23 |
The perfect storm
|
Behrens, Edward M. |
|
|
136 |
19 |
p. 2096-2097 |
artikel |
24 |
Therapy-induced mutagenesis in relapsed ALL is supported by mutational signature analysis
|
Brady, Samuel W. |
|
|
136 |
19 |
p. 2235-2237 |
artikel |
25 |
Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate
|
Lurain, Kathryn |
|
|
136 |
19 |
p. 2229-2232 |
artikel |